Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Long-Term Results Following Repair for Degenerative Mitral Regurgitation - Analysis of Factors Influencing Durability.

Gardner MA, Hossack KF, Smith IR.

Heart Lung Circ. 2019 Dec;28(12):1852-1865. doi: 10.1016/j.hlc.2018.10.011. Epub 2018 Oct 17.

PMID:
30377076
2.

Implications of Cardio-Respiratory Fitness on the Performance of Exercise Tests.

Jelinek M, Hossack K.

Heart Lung Circ. 2019 Apr;28(4):e64-e66. doi: 10.1016/j.hlc.2018.07.015. Epub 2018 Sep 4. Review.

PMID:
30269873
3.

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.

Tonkin A, Barter P, Best J, Boyden A, Furler J, Hossack K, Sullivan D, Thompson P, Vale M, Cooper C, Robinson M, Clune E; National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand.

Heart Lung Circ. 2005 Dec;14(4):275-91. No abstract available.

PMID:
16361000
4.

Nomogram for exercise capacity in women.

Hossack KF.

N Engl J Med. 2005 Nov 24;353(21):2301-3; author reply 2301-3. No abstract available.

PMID:
16306532
5.

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW.

J Am Soc Nephrol. 1997 Aug;8(8):1292-7.

6.

Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.

Ezekowitz MD, Hossack K, Mehta JL, Thadani U, Weidler DJ, Kostuk W, Awan N, Grossman W, Bommer W.

Am Heart J. 1995 Mar;129(3):527-35.

PMID:
7872184
7.

Percutaneous transluminal coronary angioplasty: clinical and quality of life outcomes one year later.

McKenna KT, McEniery PT, Maas F, Aroney CN, Bett JH, Cameron J, Holt G, Hossack KF.

Aust N Z J Med. 1994 Feb;24(1):15-21.

PMID:
8002852
8.

Clinical results and quality of life after percutaneous transluminal coronary angioplasty: a preliminary report.

McKenna KT, McEniery PT, Maas F, Aroney CN, Bett JH, Cameron J, Garrahy P, Holt G, Hossack KF, Murphy AL.

Cathet Cardiovasc Diagn. 1992 Oct;27(2):89-94.

PMID:
1446341
9.

Bepridil hydrochloride compared with placebo in patients with stable angina pectoris.

Narahara KA, Singh BN, Karliner JS, Corday SR, Hossack KF.

Am J Cardiol. 1992 Apr 9;69(11):37D-42D.

PMID:
1553890
10.

The sudden unexplained death syndrome in epilepsy: demographic, clinical, and postmortem features.

Earnest MP, Thomas GE, Eden RA, Hossack KF.

Epilepsia. 1992 Mar-Apr;33(2):310-6.

PMID:
1547760
11.
12.

Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor.

Rector WG Jr, Adair O, Hossack KF, Rainguet S.

Gastroenterology. 1990 Sep;99(3):766-70.

PMID:
2143159
13.

Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.

Rector WG Jr, Hossack KF, Ready JB.

J Hepatol. 1990 May;10(3):375-80.

PMID:
2114438
14.
15.

Atrial natriuretic factor production during upright exercise.

Hossack KF, Adair OV, Crowley ST.

Cardiology. 1990;77(6):433-42.

PMID:
2150010
16.

Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.

Kinnard DR, Harris M, Hossack KF.

Am Heart J. 1989 Nov;118(5 Pt 2):1136. No abstract available.

PMID:
2530877
17.

Transvenous biopsy diagnosis of cardiac lymphoma in an AIDS patient.

Andress JD, Polish LB, Clark DM, Hossack KF.

Am Heart J. 1989 Aug;118(2):421-3. No abstract available.

PMID:
2750666
18.

Successful repair of an atrial septal defect associated with right to left shunting.

Hossack KF, Tewksbury JC, Reid LM.

Br Heart J. 1989 Jul;62(1):69-73.

20.
21.

Hypertension in autosomal dominant polycystic kidney disease.

Bell PE, Hossack KF, Gabow PA, Durr JA, Johnson AM, Schrier RW.

Kidney Int. 1988 Nov;34(5):683-90.

22.

Echocardiographic findings in autosomal dominant polycystic kidney disease.

Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA.

N Engl J Med. 1988 Oct 6;319(14):907-12.

PMID:
3419455
23.
26.

Frequency of cardiac contusion in nonpenetrating chest injury.

Hossack KF, Moreno CA, Vanway CW, Burdick DC.

Am J Cardiol. 1988 Feb 1;61(4):391-4.

PMID:
3341218
27.

Hepatofugal portal flow in cirrhosis: observations on hepatic hemodynamics and the nature of the arterioportal communications.

Rector WG Jr, Hoefs JC, Hossack KF, Everson GT.

Hepatology. 1988 Jan-Feb;8(1):16-20.

PMID:
3338703
28.

Computer analysis of oxygen consumption and minute ventilation for the detection of the lactate threshold.

Hossack KF, Eldridge JE, Ades PA, Giansiracusa RF, Jones RH.

Cardiology. 1988;75(2):123-32.

PMID:
3130988
29.

Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.

Kinnard DR, Harris M, Hossack KF.

J Cardiovasc Pharmacol. 1988;12 Suppl 7:S110-3.

PMID:
2467119
30.

Long-term follow-up of a patient with quadruple valve replacement.

Hossack KF, Hopeman AR, Sutherland EW 3rd.

Tex Heart Inst J. 1987 Sep;14(3):315-7.

31.

Comparison of nitroglycerin patches and nifedipine.

Eldridge JE, Burdick DC, Jones RH, Hossack KF.

J Cardiovasc Pharmacol. 1987 Sep;10(3):315-9.

PMID:
2444780
32.

Cardiovascular responses to dynamic exercise.

Hossack KF.

Cardiol Clin. 1987 May;5(2):147-56. Review.

PMID:
3555794
33.

Aerobic responses to low level exercise testing following an acute myocardial infarction.

Hossack K, Eldridge J, Wolfel E, Leddy C, Berger N.

Am Heart J. 1987 Mar;113(3):694-9.

PMID:
3825859
34.

Patterns of oxygen consumption during exercise testing in peripheral vascular disease.

Eldridge JE, Hossack KF.

Cardiology. 1987;74(3):236-40.

PMID:
3594513
35.
36.

Computerized detection of the lactate threshold in coronary artery disease.

Eldridge JE, Giansiracusa RF, Jones RH, Hossack KF.

Am J Cardiol. 1986 May 1;57(13):1088-91.

PMID:
3085465
37.

Effects of the limiting symptom on the achievement of maximal oxygen consumption in patients with coronary artery disease.

Eldridge JE, Ramsey-Green CL, Hossack KF.

Am J Cardiol. 1986 Mar 1;57(8):513-7.

PMID:
3953434
38.

Relationships of working status and cardiac capacity to functional age before and after coronary bypass surgery.

Bruce RA, Kusumi F, Bruce EH, Hossack KF.

Int J Cardiol. 1985 Jun;8(2):193-204.

PMID:
3874173
39.
40.

Long-term monotherapy of angina pectoris with diltiazem.

Hossack KF, Pool PE, Seagren SC, Day B, Bruce RA.

Aust N Z J Med. 1985 Apr;15(2):221-5.

PMID:
3896216
43.

Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.

McLaran CJ, Hossack KF, Neilson GH, Siskind V.

J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):657-62.

PMID:
6206321
44.

Long-term study of high-dose diltiazem in chronic stable exertional angina.

Hossack KF, Kannagi T, Day B, Bruce RA.

Am Heart J. 1984 Jun;107(6):1215-20.

PMID:
6720548
45.

Improvement in aerobic and hemodynamic responses to exercise following aorta-coronary bypass grafting.

Hossack KF, Bruce RA, Ivey TD, Kusumi F, Kannagi T.

J Thorac Cardiovasc Surg. 1984 Jun;87(6):901-7.

PMID:
6144816
46.

Mean systolic ejection rate after aortocoronary bypass graft surgery.

Kannagi T, Hossack KF, Kusumi F, Bruce RA.

Int J Cardiol. 1984 May;5(5):613-23.

PMID:
6143735
47.
48.

Prediction of maximal cardiac output in preoperative patients with coronary artery disease.

Hossack KF, Bruce RA, Kusumi F, Kannagi T.

Am J Cardiol. 1983 Oct 1;52(7):721-6.

PMID:
6605083
49.
50.

Prognostic value of risk factors and exercise testing in men with atypical chest pain.

Hossack KF, Bruce RA, Fisher L, Hofer V.

Int J Cardiol. 1983 Apr;3(1):37-50.

PMID:
6852988

Supplemental Content

Loading ...
Support Center